Endostart

Endostart develops and manufactures a new generation of medical devices for gastrointestinal endoscopy. It creates Magnetic Balloon Technology, which improves endoscope performance and allows endoscopists to easily meet quality standards. It was founded in collaboration with CNR, public research institutions, and high-tech suppliers.

Endostart headquartered in Europe, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $267.4M in funding across 24 round(s). With a team of 1-10 employees, Endostart is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Endostart, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.